VAERS Explorer
Back to explore

Report #2873816

Received Nov 20, 2025

Life-threateningHospitalizedER / ED visitOffice visitDisabled
A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
36 yrs
State
AL
Recovered
Not recovered
Vaccinated
Apr 9, 2021
Onset
May 20, 2021
Days to onset
41
Hospital days
18

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (NOVAVAX))NOVAVAX1RS-AD26IM / RA

Symptoms (9)

Chronic inflammatory demyelinating polyradiculoneuropathyEndotracheal intubationGuillain-Barre syndromeImmunoglobulin therapyIntensive careLaboratory test abnormalMagnetic resonance imagingNeuritisRespiratory failure

Symptom narrative

COVID-19 (JANSSEN), VECTOR-NR, RS-AD26, PF, 0.5 ML - I was diagnosed with GBS about 12 weeks after getting the Janssen vaccine. I spent 6 days in ICU intubated due to lung failure and another 12 days in the hospital. I continue to get IVIG regularly for CIDP to this day (nearly 4 days later. There was no drop down for the Johnson and Johnson vaccine, so I added the information in this box.

Current illness

None

Medical history

None

Other medications

None

Allergies

None

Lab data

MRI, The facility did a full lab screening and determined nerve inflammation related to GBS.